Markers of increased angiogenesis and their correlation with biological parameters identifying high-risk patients in early B-cell chronic lymphocytic leukemia
- PMID: 17485110
- DOI: 10.1016/j.leukres.2007.03.009
Markers of increased angiogenesis and their correlation with biological parameters identifying high-risk patients in early B-cell chronic lymphocytic leukemia
Abstract
We wondered whether there was any association between the extent of increased angiogenesis and IgV(H) gene mutational status, expression of CD38 and ZAP-70 in early B-cell chronic lymphocytic leukemia (CLL) patients. Circulating levels of vascular endothelial growth factor (VEGF) correlated positively with ZAP-70-expression (P=0.03), CD38- expression (P=0.03) and mutational status of IgV(H) (P=0.005). The same did not apply when correlations were sought with either bone marrow angiogenesis or serum levels of basic fibroblatic growth factor (FGF-2). Studies to determine how to integrate variables reflecting increased angiogenesis with other prognostic markers such as CD38, ZAP-70, IgV(H) status and cytogenetic abnormalities are needed to optimize risk stratification for individual patients.
Comment in
-
Modern prognostic factors and angiogenesis in chronic lymphocytic leukemia: more data needed.Leuk Res. 2007 Dec;31(12):1763-4. doi: 10.1016/j.leukres.2007.05.016. Epub 2007 Jul 6. Leuk Res. 2007. PMID: 17617454
Similar articles
-
Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia.Am J Hematol. 2007 Sep;82(9):787-91. doi: 10.1002/ajh.20936. Am J Hematol. 2007. PMID: 17534928
-
Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia.Cancer. 2005 Nov 15;104(10):2124-32. doi: 10.1002/cncr.21437. Cancer. 2005. PMID: 16211545
-
Serum TK levels in CLL identify Binet stage A patients within biologically defined prognostic subgroups most likely to undergo disease progression.Eur J Haematol. 2006 Oct;77(4):309-17. doi: 10.1111/j.1600-0609.2006.00707.x. Epub 2006 Jul 19. Eur J Haematol. 2006. PMID: 16856923
-
Role of angiogenesis in chronic lymphocytic leukemia.Cancer. 2006 Sep 1;107(5):925-34. doi: 10.1002/cncr.22086. Cancer. 2006. PMID: 16832815 Review.
-
Prognostic markers in chronic lymphocytic leukaemia.Best Pract Res Clin Haematol. 2007 Sep;20(3):455-68. doi: 10.1016/j.beha.2007.02.001. Best Pract Res Clin Haematol. 2007. PMID: 17707833 Review.
Cited by
-
FCR and bevacizumab treatment in patients with relapsed chronic lymphocytic leukemia.Cancer. 2014 Nov 15;120(22):3494-501. doi: 10.1002/cncr.28910. Epub 2014 Jul 15. Cancer. 2014. PMID: 25043749 Free PMC article.
-
Host CD39 Deficiency Affects Radiation-Induced Tumor Growth Delay and Aggravates Radiation-Induced Normal Tissue Toxicity.Front Oncol. 2020 Oct 22;10:554883. doi: 10.3389/fonc.2020.554883. eCollection 2020. Front Oncol. 2020. PMID: 33194619 Free PMC article.
-
Does adiponectin act as an antiangiogenic factor in B-cell chronic lymphocytic leukemia?Adv Hematol. 2009;2009:287974. doi: 10.1155/2009/287974. Epub 2009 Aug 27. Adv Hematol. 2009. PMID: 19960063 Free PMC article.
-
Large-scale analysis of DNA methylation in chronic lymphocytic leukemia.Epigenomics. 2009 Oct;1(1):39-61. doi: 10.2217/epi.09.10. Epigenomics. 2009. PMID: 20495622 Free PMC article.
-
Advancements in leukemia management: Bridging diagnosis, prognosis and nanotechnology (Review).Int J Oncol. 2024 Dec;65(6):112. doi: 10.3892/ijo.2024.5700. Epub 2024 Oct 4. Int J Oncol. 2024. PMID: 39364739 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials